Picture of Catalyst Pharmaceuticals logo

CPRX — Catalyst Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Brief: Catalyst Pharmaceuticals Q2 Revenue USD 99.6 Million Vs. IBES Estimate USD 91.7 Million

Aug 09 (Reuters) - Catalyst Pharmaceuticals Q2 net income USD 37.8 million.
* Q2 operating income USD 46.7 million
* Q2 adjusted net income USD 60.4 million
* outlook FY revenue USD 380-390 million

Recent news on Catalyst Pharmaceuticals

See all news